Healthcare -
Biotechnology - NASDAQ - BM
$ 29.76
2.22 %
$ 2.17 B
Market Cap
-118.08
P/E
KNSA - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities KNSA - Kiniksa Pharmaceuticals, Ltd.
37.7 M
LAST VALUE
158.14%
2 YEAR CAGR
-5.20%
5 YEAR CAGR
0.00%
10 YEAR CAGR